Post-transplantation cyclophosphamide (Cy) as a single agent for GVHD prophylaxis after HLA matched related and unrelated bone marrow transplantation

被引：0
|
作者：
Luznik, L [1 ]
Chen, A [1 ]
Fuchs, EJ [1 ]
Phelps, M [1 ]
Crawford, A [1 ]
Brodsky, RA [1 ]
Huff, CA [1 ]
Jones, RJ [1 ]
机构：
[1] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2006年 / 12卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2005.11.081
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
65
引用
收藏
页码：26 / 26
页数：1
相关论文
共 50 条
  • [31] Post-Transplant Cyclophosphamide for Gvhd Prophylaxis in Matched Unrelated Donor Transplantation Compared to ATG-Based Prophylaxis
    Bailen, Rebeca
    Kwon, Mi
    Jesus Pascual-Cascon, Maria
    Torrent, Anna
    Ferra, Christelle M.
    Sanz, Jaime
    Doblas-Marquez, Alberto
    Benitez, Olga
    Pinana Sanchez, Jose Luis
    Oarbeascoa, Gillen
    Dorado, Nieves
    Cristina, Munoz
    Martinez-Laperche, Carolina
    Anguita, Javier
    Buno, Ismael
    Luis Diez-Martin, Jose
    BLOOD, 2019, 134
  • [32] A phase II study of post-transplant cyclophosphamide combined with tacrolimus for GVHD prophylaxis after HLA-matched related/unrelated allogeneic hematopoietic stem cell transplantation
    Nakamae, Hirohisa
    Nakane, Takahiko
    Okamura, Hiroshi
    Koh, Hideo
    Nakashima, Yasuhiro
    Hirose, Asao
    Nakamae, Mika
    Nishimoto, Mitsutaka
    Kuno, Masatomo
    Makuuchi, Yosuke
    Harada, Naonori
    Takakuwa, Teruhito
    Hino, Masayuki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 115 (01) : 77 - 86
  • [33] Post-Transplantation Cyclophosphamide for Prevention of Graft-Versus-Host Disease after HLA-Matched Related and Unrelated Donor Peripheral Blood Stem Cell Transplantation
    Miekarek, Marco
    Furlong, Terry
    O'Donnell, Paul V.
    Storer, Barry E.
    McCune, Jeannine S.
    Storb, Rainer F.
    Carpenter, Paul A.
    Flowers, Mary E. D.
    Appelbaum, Frederick R.
    Martin, Paul J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S406 - S406
  • [34] A phase II study of post-transplant cyclophosphamide combined with tacrolimus for GVHD prophylaxis after HLA-matched related/unrelated allogeneic hematopoietic stem cell transplantation
    Hirohisa Nakamae
    Takahiko Nakane
    Hiroshi Okamura
    Hideo Koh
    Yasuhiro Nakashima
    Asao Hirose
    Mika Nakamae
    Mitsutaka Nishimoto
    Masatomo Kuno
    Yosuke Makuuchi
    Naonori Harada
    Teruhito Takakuwa
    Masayuki Hino
    International Journal of Hematology, 2022, 115 : 77 - 86
  • [35] Haploidentical versus Matched Unrelated versus Matched Sibling Donor Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide
    Mehta, Rohtesh S.
    Saliba, Rima M.
    Ghanem, Sassine
    Alousi, Amin M.
    Rondon, Gabriela
    Anderlini, Paolo
    Al-Atrash, Gheath
    Bashir, Qaiser
    Hosing, Chitra M.
    Im, Jin S.
    Kebriaei, Partow
    Khouri, Issa
    Marin, David
    Nieto, Yago
    Olson, Amanda
    Oran, Betul
    Popat, Uday R.
    Qazilbash, Muzaffar H.
    Ramdial, Jeremy
    Saini, Neeraj
    Srour, Samer A.
    Champlin, Richard E.
    Rezvani, Katayoun
    Shpall, Elizabeth J.
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (07): : 395.e1 - 395.e11
  • [36] Haploidentical bone marrow and stem cell transplantation: experience with post-transplantation cyclophosphamide
    Robinson, Tara M.
    O'Donnell, Paul V.
    Fuchs, Ephraim J.
    Luznik, Leo
    SEMINARS IN HEMATOLOGY, 2016, 53 (02) : 90 - 97
  • [37] HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide versus HLA-Matched Unrelated Donor Transplantation for Myelodysplastic Syndrome
    Nakaya, Yosuke
    Koh, Hideo
    Konuma, Takaaki
    Shimomura, Yoshimitsu
    Ishiyama, Ken
    Itonaga, Hidehiro
    Hino, Masayuki
    Doki, Noriko
    Nishida, Tetsuya
    Ohigashi, Hiroyuki
    Matsuoka, Ken-ichi
    Kanda, Yoshinobu
    Maruyama, Yumiko
    Sawa, Masashi
    Eto, Tetsuya
    Hiramoto, Nobuhiro
    Fukuda, Takahiro
    Atsuta, Yoshiko
    Nakamae, Hirohisa
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (03): : 316.e1 - 316.e12
  • [38] Mycophenolate Mofetil: A Friend or a Foe with Post-Transplantation Cyclophosphamide and Tacrolimus Prophylaxis in HLA-Matched Donors?
    Mehta, Rohtesh S.
    Saliba, Rima M.
    Hayase, Eiko
    Jenq, Robert R.
    Abraham, Susan
    Rashid, Asif
    Rondon, Gabriela
    Al-Atrash, Gheath
    Bashir, Qaiser
    Hosing, Chitra M.
    Kebriaei, Partow
    Khouri, Issa
    Marin, David
    Nieto, Yago
    Olson, Amanda
    Oran, Betul
    Popat, Uday R.
    Qazilbash, Muzaffar H.
    Ramdial, Jeremy
    Srour, Samer
    Champlin, Richard E.
    Rezvani, Katayoun
    Shpall, Elizabeth J.
    Alousi, Amin M.
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (08): : 500.e1 - 500.e10
  • [39] Thyrotoxicosis after matched unrelated bone marrow transplantation
    Tatevossian, R
    Blair, JC
    Plowman, PN
    Savage, MO
    Shankar, AG
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2004, 26 (08) : 529 - 531
  • [40] Defining An Optimal Therapeutic Range for Busulfan (Bu) Administered with Pre-and Post-Transplant Cyclophosphamide (Cy) In HLA-Matched Related and Unrelated Bone Marrow Transplantation (BMT)
    Lombardi, Lindsey R.
    Zahurak, Marianna
    Durakovic, Nadira
    Kowalski, Jeanne
    Jones, Richard J.
    Luznik, Leo
    BLOOD, 2010, 116 (21) : 1427 - 1427
12345